Design and In-vitro Evaluation of a Modified-release Oral Dosage Form of Nifedipine by Hybridization of Hydroxypropyl-β-cyclodextrin and Hydroxypropylcellulose

1993 ◽  
Vol 45 (11) ◽  
pp. 942-946 ◽  
Author(s):  
ZHENG WANG ◽  
TAKASHI HORIKAWA ◽  
FUMITOSHI HIRAYAMA ◽  
KANETO UEKAMA
Keyword(s):  
Dosage Form ◽  
Oral Dosage ◽  
Modified Release ◽  
In Vitro Evaluation ◽  
Oral Dosage Form

Design and in vitro evaluation of a novel poly(methacrylic acid)/metronidazole antibacterial nanogel as an oral dosage form

2014 ◽  
Vol 118 ◽  
pp. 65-71 ◽  
Author(s):  
Tao Chen ◽  
Liang Chen ◽  
Haicheng Li ◽  
Yuhui Chen ◽  
Huixin Guo ◽  
...  
Keyword(s):  
Methacrylic Acid ◽  
Dosage Form ◽  
Oral Dosage ◽  
In Vitro Evaluation ◽  
Oral Dosage Form

Design and In Vitro Evaluation of Slow-Release Dosage Form of Pretanide: Utility of β-Cyclodextrin:Cellulose Derivative Combination as a Modified-Release Drug Carrier

1990 ◽  
Vol 79 (3) ◽  
pp. 244-248 ◽  
Author(s):  
Kaneto Uekama ◽  
Kazutaka Matsubara ◽  
Kentaro Abe ◽  
Yasuhide Horiuchi ◽  
Fumitoshi Hirayama ◽  
...  
Keyword(s):  
Dosage Form ◽  
Slow Release ◽  
Drug Carrier ◽  
Modified Release ◽  
In Vitro Evaluation ◽  
Release Drug

scholarly journals Statistical optimization of alginate-based oral dosage form of 5-aminosalicylic acid aimed to colonic delivery: In vitro and in vivo evaluation

2019 ◽  
Vol 52 ◽  
pp. 177-188 ◽  
Author(s):  
Ehsan Kaffash ◽  
Farinaz Saremnejad ◽  
Mohammadreza Abbaspour ◽  
Seyed Ahmad Mohajeri ◽  
Hadi Afrasiabi Garekani ◽  
...  
Keyword(s):  
Dosage Form ◽  
Statistical Optimization ◽  
Oral Dosage ◽  
Aminosalicylic Acid ◽  
Colonic Delivery ◽  
In Vivo Evaluation ◽  
Oral Dosage Form

Prescriptions Ordered by Podiatrists for Ambulatory Patients

1978 ◽  
Vol 12 (12) ◽  
pp. 720-727
Author(s):  
T. Donald Rucker ◽  
Leonard Janis ◽  
Marialice Bennett
Keyword(s):  
Quality Of Care ◽  
Pilot Study ◽  
Dosage Form ◽  
Oral Dosage ◽  
Survey Period ◽  
Oral Dosage Form ◽  
Ambulatory Patients

This pilot study describes and suggests quality of care considerations related to prescriptions ordered by podiatrists for ambulatory patients. During the four-month survey period, the average podiatrist initiated 120 prescription orders and utilized 26 different drug entities. The 44 practitioners employed 235 different preparations, headed by Lotrimin®, Mepergan Fortis® and erythromycin. Although refill orders were judged as conservative, questions are raised about the use of oral dosage form combination products, agents employed infrequently, and the desired therapeutic intention of some preparations.

Sign in / Sign up

Export Citation Format

Share Document